DrugDoctor,
I'm not sure if recall our chats about 3 years ago when I found this board, but I have to disagree. I worked as a contractor for a company that was purchased by PAWS. I received stock for my work. I've owned this stock since.
If you think that a company can't "morph into a totally new entity", then please let me know how a compounding drug company relates to a company that flies pets on airplanes.
Paws kept up on their filings which made them a good target for use as a shell company to take over by a new company to get a stock ticker.
As bad as the filings might be, if Pxyn does file, they can be a shell for any new company to get publically traded in a quicker manner.
News 
Market Data 
Discover 
